We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.52%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$15.3B
AUM Growth
+$933M
(+6.5%)
Cap. Flow
+$1.09B
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
20.85%
Holding
1,816
New
17
Increased
573
Reduced
1,124
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$111M |
| 2 |
Amazon
AMZN
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$91.8M |
| 4 |
Roper Technologies
ROP
|
+$69.8M |
| 5 |
PX
Praxair Inc
PX
|
+$68.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown-Forman Class B
BF.B
|
+$28.4M |
| 2 |
Becton Dickinson
BDX
|
+$28M |
| 3 |
W.W. Grainger
GWW
|
+$20.5M |
| 4 |
Lowe's Companies
LOW
|
+$15M |
| 5 |
Target
TGT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Financials | 13.66% |
| 3 | Healthcare | 12.92% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Editas Medicine
EDIT
$399M
| $875K | 0.01% |
26,405
-1,398
| -5% | -$49.8K |
|
877
First Solar
FSLR
$21.8B
| $875K | 0.01% |
12,323
-790
| -6% | -$53.8K |
|
878
Diamondrock Hospitality Co
DRH
$2.63B
| $874K | 0.01% |
83,758
-5,007
| -6% | -$55.3K |
|
879
LivaNova
LIVN
$4.3B
| $874K | 0.01% |
9,872
-1,079
| -10% | -$91.9K |
|
880
Steris
STE
$20.9B
| $874K | 0.01% |
9,358
-333
| -3% | -$30.3K |
|
881
Blackstone Mortgage Trust
BXMT
$2.82B
| $872K | 0.01% |
27,763
-102
| -0.4% | -$3.2K |
|
882
ATI
ATI
$27B
| $871K | 0.01% |
36,772
-2,564
| -7% | -$68.8K |
|
883
Atara Biotherapeutics
ATRA
$71.2M
| $864K | 0.01% |
886
+68
| +8% | +$62K |
|
884
Palo Alto Networks
PANW
$264B
| $864K | 0.01% |
28,548
+5,406
| +23% | +$150K |
|
|
MNTA
885
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $864K | 0.01% |
47,582
-7,117
| -13% | -$119K |
|
|
QCP
886
DELISTED
Quality Care Properties, Inc.
QCP
| $863K | 0.01% |
44,406
-2,698
| -6% | -$40.3K |
|
887
Acadia Realty Trust
AKR
$2.99B
| $857K | 0.01% |
34,830
-2,068
| -6% | -$50.8K |
|
888
NVR
NVR
$17.2B
| $857K | 0.01% |
306
-18
| -6% | -$57.2K |
|
|
DISCK
889
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $856K | 0.01% |
43,853
+15,841
| +57% | +$355K |
|
|
CMD
890
DELISTED
Cantel Medical Corporation
CMD
| $852K | 0.01% |
7,646
+1,164
| +18% | +$130K |
|
891
Jack Henry & Associates
JKHY
$10.7B
| $851K | 0.01% |
7,039
-185
| -3% | -$22.5K |
|
892
Lumentum
LITE
$59.4B
| $850K | 0.01% |
13,325
-337
| -2% | -$19.3K |
|
893
Opko Health
OPK
$921M
| $849K | 0.01% |
267,970
-43,216
| -14% | -$174K |
|
|
CIM
894
Chimera Investment
CIM
$1.05B
| $848K | 0.01% |
16,235
-322
| -2% | -$16.9K |
|
895
Woodward
WWD
$25B
| $847K | 0.01% |
11,826
-1,276
| -10% | -$96.1K |
|
896
Iovance Biotherapeutics
IOVA
$2.23B
| $844K | 0.01% |
49,940
+1,671
| +3% | +$25.3K |
|
897
Cirrus Logic
CRUS
$6.74B
| $841K | 0.01% |
20,695
-1,407
| -6% | -$65.3K |
|
|
AKCA
898
DELISTED
Akcea Therapeutics Inc
AKCA
| $838K | 0.01% |
32,725
-5,351
| -14% | -$115K |
|
899
Olin
OLN
$2.64B
| $836K | 0.01% |
27,521
+377
| +1% | +$12.8K |
|
900
Prothena Corp
PRTA
$458M
| $836K | 0.01% |
22,784
-3,631
| -14% | -$132K |
|
Similar funds
ProShare Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, ProShare Advisors held 1,816 positions worth $15.3B, up 6.5% from $14.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $1.09B of net new capital in Q1 2018, opening 17 new positions and adding to 573 existing holdings. Its largest new stake was CoStar Group: 93,260 shares worth $3.38M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Brown-Forman Class B, an estimated $28.4M trimmed.
- ProShare Advisors's largest Q1 2018 buy was CoStar Group: 93,260 shares worth $3.38M.
- ProShare Advisors added most to Apple in Q1 2018, an estimated $111M increase.
- ProShare Advisors's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $28.4M.
- ProShare Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $3.8M.
- ProShare Advisors's ten largest holdings make up 21% of its $15.3B portfolio in Q1 2018.
- ProShare Advisors opened 17 new positions and closed 101 in Q1 2018.
- ProShare Advisors's portfolio value rose 6.5% quarter-over-quarter to $15.3B.
Based on ProShare Advisors's 13F filing for Q1 2018, filed 14 May 2018.